Comparison of cross-sectional HIV incidence assay results from dried blood spots and plasma.

Comparison of cross-sectional HIV incidence assay results from dried blood spots and plasma.

BACKGROUND:Assays have been developed for cross-sectional HIV incidence estimation using plasma samples. Large scale surveillance programs are planned using dried blood spot (DBS) specimens for incidence assessment. However, limited information exists on the performance of HIV cross-sectional incide...

Full description

Bibliographic Details
Main Authors:	Katherine E Schlusser, Christopher Pilcher, Esper G Kallas, Breno R Santos, Steven G Deeks, Shelley Facente, Sheila M Keating, Michael P Busch, Gary Murphy, Alex Welte, Thomas Quinn, Susan H Eshleman, Oliver Laeyendecker
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2017-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC5322916?pdf=render

Similar Items

Challenges to the performance of current HIV diagnostic assays and the need for centralized specimen archives: a review of the Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA) repository [version 1; peer review: 2 approved, 1 approved with reservations]
by: Shelley N. Facente, et al.
Published: (2019-07-01)

HIV antibodies as markers of HIV systemic reservoir and replication activity
by: S.M. Keating, et al.
Published: (2015-12-01)

Interpreting HIV diagnostic histories into infection time estimates: analytical framework and online tool
by: Eduard Grebe, et al.
Published: (2019-10-01)

Pregnancy does not affect HIV incidence test results obtained using the BED capture enzyme immunoassay or an antibody avidity assay.
by: Oliver Laeyendecker, et al.
Published: (2010-10-01)

Performance of rapid point-of-care and laboratory tests for acute and established HIV infection in San Francisco.
by: Christopher D Pilcher, et al.
Published: (2013-01-01)

Quantitation of 5-Methyltetrahydrofolic Acid in Dried Blood Spots and Dried Plasma Spots by Stable Isotope Dilution Assays.
by: Markus Kopp, et al.
Published: (2015-01-01)

The effect of sample handling on cross sectional HIV incidence testing results.
by: Oliver Laeyendecker, et al.
Published: (2011-01-01)

Development and Implementation of Dried Blood Spot-Based COVID-19 Serological Assays for Epidemiologic Studies
by: Marcus P. Wong, et al.
Published: (2022-06-01)

Clinical Evaluation of an Affordable Qualitative Viral Failure Assay for HIV Using Dried Blood Spots in Uganda.
by: Sheila N Balinda, et al.
Published: (2016-01-01)

Use of HIV Recency Assays for HIV Incidence Estimation and Other Surveillance Use Cases: Systematic Review
by: Shelley N Facente, et al.
Published: (2022-03-01)

Next generation viral outgrowth assays as proxies for classic QVOA to measure HIV-1 reservoir size
by: M. Stone, et al.
Published: (2017-12-01)

Blood and dried blood spot telomere length measurement by qPCR: assay considerations.
by: DeAnna L Zanet, et al.
Published: (2013-01-01)

Diagnosis, antiretroviral therapy, and emergence of resistance to antiretroviral agents in HIV-2 infection: a review
by: Maia Hightower, et al.

Statistical analysis of single-copy assays when some observations are zero
by: Peter Bacchetti, et al.
Published: (2019-07-01)

Validation and development of an immunonephelometric assay for the determination of alpha-1 antitrypsin levels in dried blood spots from patients with COPD
by: Laura Russo Zillmer, et al.
Published: (2013-09-01)

Application of a dried blood spot based proteomic and genetic assay for diagnosing hereditary angioedema
by: Marius‐Ionuţ Iuraşcu, et al.
Published: (2023-11-01)

Evaluation of dried blood spots with a multiplex assay for measuring recent HIV-1 infection.
by: Kelly A Curtis, et al.
Published: (2014-01-01)

Usefulness of automated assays for detecting hepatitis B and C markers in dried blood spot samples
by: Livia Melo Villar, et al.
Published: (2019-08-01)

Diagnosis of Morquio Syndrome in Dried Blood Spots Based on a New MRM-MS Assay.
by: Claudia Cozma, et al.
Published: (2015-01-01)

Inter-laboratory assessment of a prototype multiplex kit for determination of recent HIV-1 infection.
by: Kelly A Curtis, et al.
Published: (2013-01-01)

Minimizing the variables of voiding spot assay for comparison between laboratories
by: Chuang Luo, et al.
Published: (2023-05-01)

Use of a high resolution melting (HRM) assay to compare gag, pol, and env diversity in adults with different stages of HIV infection.
by: Matthew M Cousins, et al.
Published: (2011-01-01)

Validation of a quantitative multiplex LC-MS/MS assay of carvedilol, enalaprilat, and perindoprilat in dried blood spots from heart failure patients and its cross validation with a plasma assay
by: Andre Joubert, et al.
Published: (2023-01-01)

Pre-Analytical and Clinical Validation of a Dried Blood Spot Assay for Asymmetric Dimethylarginine and L-Arginine
by: Juliane Hannemann, et al.
Published: (2020-04-01)

Screening of Neonatal UK Dried Blood Spots Using a Duplex SMN1 Screening Assay
by: Stuart P. Adams, et al.
Published: (2021-10-01)

LC-MS/MS-based enzyme assay for lysosomal acid lipase using dried blood spots
by: Mari Ohira, et al.
Published: (2022-12-01)

HIV Antibody Profiles in HIV Controllers and Persons With Treatment-Induced Viral Suppression
by: Kai Kammers, et al.
Published: (2021-08-01)

Effect of natural and ARV-induced viral suppression and viral breakthrough on anti-HIV antibody proportion and avidity in patients with HIV-1 subtype B infection.
by: Sarah K Wendel, et al.
Published: (2013-01-01)

Interferon-gamma FlowSpot assay for the measurement of the T-cell response to cytomegalovirus
by: Qianyu Ye, et al.
Published: (2023-06-01)

Automation of yeast spot assays using an affordable liquid handling robot
by: Shodai Taguchi, et al.
Published: (2023-04-01)

Stepping up ELISpot: Multi-Level Analysis in FluoroSpot Assays
by: Sylvia Janetzki, et al.
Published: (2014-11-01)

Development of an EliSPOT assay for detection of CMV-specific immune response
by: Maria Elena Terlizzi, et al.
Published: (2010-06-01)

Mapping of domain-mediated protein-protein interaction by SPOT peptide assay
by: Xiaoyi Mao, et al.
Published: (2021-06-01)

A “NEW” way to look at an “old” test: Transforming the void spot assay (VSA) into a diagnostic tool
by: Marianela G. Dalghi
Published: (2021-08-01)

Evaluation of LAMP for the diagnosis of Loa loa infection in dried blood spots compared to PCR-based assays and microscopy
by: Thuy-Huong Ta-Tang, et al.
Published: (2022-02-01)

A comparison of two measures of HIV diversity in multi-assay algorithms for HIV incidence estimation.
by: Matthew M Cousins, et al.
Published: (2014-01-01)

Evaluation of the performance of Abbott m2000 and Roche COBAS Ampliprep/COBAS Taqman assays for HIV-1 viral load determination using dried blood spots and dried plasma spots in Kenya.
by: Clement Zeh, et al.
Published: (2017-01-01)

High seroprevalence for SARS-CoV-2 among household members of essential workers detected using a dried blood spot assay.
by: Thomas W McDade, et al.
Published: (2020-01-01)

Analysis of HIV using a high resolution melting (HRM) diversity assay: automation of HRM data analysis enhances the utility of the assay for analysis of HIV incidence.
by: Matthew M Cousins, et al.
Published: (2012-01-01)

VIP-SPOT: an Innovative Assay To Quantify the Productive HIV-1 Reservoir in the Monitoring of Cure Strategies
by: Maria C. Puertas, et al.
Published: (2021-06-01)